重大公告
Mr. Michael Chang and five other executives received an acquittal for insider trading case at second instance by Taiwan High Court
Parties to the legal matter: Michael Chang (Chairman); Youe-Kong Shue (Former Vice Chairman); Amy Hung (Former General Manager); Tony Yu (Former Chief Science Officer); Jon-Jin …
OBI Pharma Inc. to attend the 39th Annual J.P. Morgan Healthcare Conference
1. Date of the event: Jan 12, 2021 2. Time: 00:00:00 NST 3. Location: Virtual Event 4. Summary: OBI Pharma Inc. to attend the 39th …
OBI capital increases by issuance of stocks to transfer stocks with Amaran Biotechnology Inc. (Announcement of base day and trading counterparty)
1. Type of merger and acquisition (e.g., merger, spin-off, acquisition, or share transfer): Share transfer 2. Date of occurrence of the event: Dec 31, 2020 …
The active cancer immunotherapy OBI-822, Adagloxad Simolenin, has been granted by National Medical Products Administration (NMPA) to proceed Phase III human clinical study
1. Date of occurrence of the event: Dec 25, 2020 2. Company name: OBI Pharma Inc. 3. Relationship to the Company (please enter “head office” …
OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities
Contents: 1.Date of institutional investor conference: Dec 21, 2020 2.Time of institutional investor conference: 14:30:00 NST 3.Location of institutional investor conference: Masterlink Securities (Address: No.97-11, …